Sofwave Medical reported Q2 2026 revenue of $30 million, a 43% year-over-year increase, reflecting robust adoption of its ultrasound-based microneedling platform. The company has been gaining traction in the competitive energy-device space against RF and laser competitors.
Devices & Tech
Sofwave Q2 Revenue Jumps 43% YoY to $30M
Ultrasound microneedling device maker posts strong growth, signaling sustained demand for energy-based platforms.
Sofwave posts 43% YoY growth, signaling sustained demand for ultrasound microneedling over RF and laser.
For practice owners evaluating device acquisition, Sofwave's trajectory matters. Ultrasound microneedling offers a differentiated mechanism—mechanical disruption plus thermal energy at controlled depth—without the downtime or tissue damage risk of aggressive RF. The 43% growth suggests practices are rotating capital toward this modality, likely for skin tightening and collagen remodeling in the face and neck. Device leasing and per-treatment economics will be key; strong manufacturer revenue growth often precedes price increases or tighter rebate terms. Practices should benchmark current lease rates and utilization thresholds before rates shift.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.